Cathy graduated from Indiana University Southeast with a bachelor's degree in English. Over her nine-year content writing career, Cathy has developed a knack for untangling complex information and ...
BriaCell Therapeutics ( ($TSE:BCT) ) has shared an announcement. BriaCell Therapeutics has announced the presentation of promising Phase 2 and ...
Bristol Myers will enroll more patients in its Cobenfy Alzheimer's psychosis study after site irregularities, with ...
Speaking at CDMI Europe 2025, GlobalData pharma analyst George El-Helou says the use of AI in R&D could help mitigate patent ...
CytomX Therapeutics has recently seen its consensus analyst price target rise from $6.14 to $7.07 per share, reflecting growing optimism about the company’s outlook as its lead asset moves forward in ...